Ramachandra Reddy
Ramachandra Reddy Ankireddypalle, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20130262615 | SHARED NETWORK-AVAILABLE STORAGE THAT PERMITS CONCURRENT DATA ACCESS - Techniques for providing shared access to, e.g., a small computer system interface (SCSI) storage device in a computer network include providing an operational mode on SCSI interfaces with a first media agent and a second media agent such that, in response to inquiry messages on the SCSI interfaces, the SCSI storage device appears as a SCSI target device to the first media agent and the second media agent and mapping data operations between the first media agent and the SCSI storage device and the second media agent and the SCSI storage device to logically unique channel numbers for the first media agent and the second media agent to perform data storage operations over their respective SCSI interfaces by concurrently sharing the SCSI storage device. | 10-03-2013 |
Ramachandra Reddy Arjula, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20090047707 | Bacterial recombinant phytase - A novel phytase enzyme obtainable from B. Subtilis strain ARRMK-33 is disclosed. Also a novel method to produce recombinant phytase protein in prokaryotic cells is disclosed. | 02-19-2009 |
Ramachandra Reddy Yeluri, Prakasam IN
Patent application number | Description | Published |
---|---|---|
20100048607 | FORMULATIONS COMPRISING PALONOSETRON - Pharmaceutical compositions comprising palonosetron and its pharmaceutically acceptable salts, in the form of a ready-to-use solution or a lyophilized form. Specific embodiments of the invention relate to stable pharmaceutical formulations of palonosetron and its pharmaceutically acceptable salts, wherein the formulation does not comprise a chelating agent or an antioxidant. | 02-25-2010 |
20120238596 | FORMULATIONS COMPRISING PALONOSETRON - Pharmaceutical compositions comprising palonosetron and its pharmaceutically acceptable salts, in the form of a ready-to-use solution or a lyophilized form. Specific embodiments of the invention relate to stable pharmaceutical formulations of palonosetron and its pharmaceutically acceptable salts, wherein the formulation does not comprise a chelating agent or an antioxidant. | 09-20-2012 |